Day: June 6, 2026

Benzothiazole Inhibitor Targets Pan-Sarbecovirus ACE2

In a groundbreaking development poised to reshape antiviral therapeutic strategies, researchers Liu, Bai, Zhou, and colleagues have unveiled a novel benzothiazole-based allosteric inhibitor that targets the human angiotensin-converting enzyme 2 (ACE2) receptor, demonstrating

Read More »